• 881 Citations
  • 16 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

My current research encompasses treatment strategies and biomarker discovery for Motor Neuron Disease (also known as Amyotrophic Lateral Sclerosis).

After completing a PhD at Adelaide University in December 2003, I undertook postdoctoral studies in the Neurotrophic Laboratory at Flinders University. I now lead the research undertaken in the Neurotrophic Laboratory.

ORCID https://orcid.org/0000-0002-3482-8741

My lab webpage can be found at: http://www.flinders.edu.au/neuroscience/lab_mnd.html

Research Interests

Motor Neuron Disease - developing novel treatment strategies,  biomarkers and causative factors for motor neuron disease.
Neurotrophins and neurotrophin receptors - how they function in the nervous system and immune system.

Fingerprint Dive into the research topics where Mary-Louise Rogers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 881 Citations
  • 16 h-Index
  • 28 Article
  • 8 Paper
  • 2 Chapter
  • 1 Comment/debate

Removal of p75 Neurotrophin Receptor Expression from Cholinergic Basal Forebrain Neurons Reduces Amyloid-β Plaque Deposition and Cognitive Impairment in Aged APP/PS1 Mice

Qian, L., Milne, M. R., Shepheard, S., Rogers, M. L., Medeiros, R. & Coulson, E. J., 1 Jul 2019, In : MOLECULAR NEUROBIOLOGY. 56, 7, p. 4639-4652 14 p.

Research output: Contribution to journalArticle

  • 6 Citations (Scopus)

    Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial

    Gold, J., Rowe, D. B., Kiernan, M. C., Vucic, S., Mathers, S., van Eijk, R. P. A., Nath, A., Garcia Montojo, M., Norato, G., Santamaria, U. A., Rogers, M. L., Malaspina, A., Lombardi, V., Mehta, P. R., Westeneng, H. J., van den Berg, L. H. & Al-Chalabi, A., 1 Jul 2019, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20, 7-8, p. 595-604 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 10 Citations (Scopus)
    4 Downloads (Pure)

    Non-viral gene therapy that targets motor neurons in vivo

    Rogers, M-L., Smith, K., Matusica, D., Fenech, M., Hoffman, L., Rush, R. & Voelcker, N., 2018, Gene Therapy for the Central and Peripheral Nervous System. Frontiers Media, p. 10-21 12 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Open Access
  • 6 Downloads (Pure)

    Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort.

    Jia, R., Shepheard, S., Jin, J., Hu, F., Zhao, X., Xue, L., Xiang, L., Qi, H., Qu, Q., Guo, F., Rogers, M-L. & Dang, J., 2017, In : Scientific Reports. 7, 1, 8 p., 5127.

    Research output: Contribution to journalArticle

  • 6 Citations (Scopus)

    Urinary p75ECD: A prognostic, disease progression, and pharmacodynamic biomarker in ALS

    Shepheard, S., Wuu, J., Cardoso, M., Wiklendt, L., Dinning, P., Chataway, T., Schultz, D., Benatar, M. & Rogers, M-L., 2017, In : Neurology. 88, 12, p. 1137-1143 7 p.

    Research output: Contribution to journalArticle

  • 34 Citations (Scopus)